dc.contributor.author |
Mihaluța, Viorica |
|
dc.contributor.author |
Stoian, Alina |
|
dc.contributor.author |
Ignatova, Olga |
|
dc.contributor.author |
Raischi, Ion |
|
dc.contributor.author |
Verega, Grigore |
|
dc.contributor.author |
Nacu, Viorel |
|
dc.date.accessioned |
2024-04-19T10:21:10Z |
|
dc.date.available |
2024-04-19T10:21:10Z |
|
dc.date.issued |
2024 |
|
dc.identifier.citation |
MIHALUȚA ,Viorica, STOIAN, Alina, IGNATOVA, Olga, et al. Amniotic membrane transplantation into lower limb ulcers. In: Cells and Tissues Transplantation. Actualities and Perspectives: the materials of the nat. scientific conf. with internat. particip., the 2nd ed. Chisinau, March 29-30th 2024: [abstracts]. Chişinău: CEP Medicina, 2024, p. 17. ISBN 978-9975-82-366-1. |
en_US |
dc.identifier.isbn |
978-9975-82-366-1 |
|
dc.identifier.uri |
http://repository.usmf.md/handle/20.500.12710/27024 |
|
dc.description.abstract |
Background.There are many applications of the amniotic membrane in regenerative medicine, it
serves as a source of stem cells and potent growth factors and like a very biocompatible natural
scaffold; also the amniotic membrane serves as an efficacious nanorecipient for medicines delivery,
due to its raised entrapment properties.
Materials and methods. Was performed a controlled clinical study, which were involved 10 patients,
who suffered from neuropathic foot ulcers, and treated by amniotic membrane transplant. The age of
patients was between 18-70 years and suffered from ulceration below the ankle for a month or more.
Results. The main result of this study was to assess the proportion of ulcers, that full closure in 9 weeks
in treated with amniotic membrane. Thus, 78% of all patients obtained full closure.
Conclusion. The clinical application of amniotic membranes maintains the anatomical and structural
configuraAmniotic membrane transplantation is a common practice in regenerative medicine due to
its potential to provide stem cells and potent growth factors. It is also a biocompatible natural scaffold
that can be used as an effective nanorecipient for delivering medicine. |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
CEP Medicina |
en_US |
dc.relation.ispartof |
Cells and tissues transplantation. Actualities and perspectives. The 2-nd edition. Chisinau, March 29-30th 2024 |
en_US |
dc.subject |
neuropathic |
en_US |
dc.subject |
amniotic |
en_US |
dc.subject |
regenerative |
en_US |
dc.subject |
ulcers |
en_US |
dc.title |
Amniotic membrane transplantation into lower limb ulcers |
en_US |
dc.type |
Other |
en_US |